| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.0091 | 0.8 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.0092 | 0.8 |